Dr Nicole Sherron Carter-loebig, MD, CNM in Bethesda, MD - Medicare Student in an Organized Health Care Education/Training Program

Dr Nicole Sherron Carter-loebig, MD, CNM is a medicare enrolled "Student In An Organized Health Care Education/training Program" in Bethesda, Maryland. Her current practice location is 8901 Wisconsin Ave, Bethesda, Maryland. You can reach out to her office (for appointments etc.) via phone at (301) 295-4611.

Dr Nicole Sherron Carter-loebig is licensed to practice in * (Not Available) (license number ) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1639155641.

Contact Information

	Dr Nicole Sherron Carter-loebig, MD, CNM
	8901 Wisconsin Ave, Bethesda, MD 20889-0004
	(301) 295-4611
	Not Available

Provider's Profile

Full Name	Dr Nicole Sherron Carter-loebig
Gender	Female
Speciality	Student In An Organized Health Care Education/training Program
Location	8901 Wisconsin Ave, Bethesda, Maryland
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1639155641
Provider Enumeration Date: 12/21/2005
Last Update Date: 06/24/2012

Medicare PECOS Information:

PECOS PAC ID: 4284660945
Enrollment ID: I20130508000119

Medical Identifiers

Medical identifiers for Dr Nicole Sherron Carter-loebig such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1639155641	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
367A00000X	Advanced Practice Midwife	MW010070 (Pennsylvania)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Nicole Sherron Carter-loebig is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Nicole Sherron Carter-loebig, MD, CNM 8901 Wisconsin Ave, Bethesda, MD 20889-0004 Ph: (301) 295-4611	Dr Nicole Sherron Carter-loebig, MD, CNM 8901 Wisconsin Ave, Bethesda, MD 20889-0004 Ph: (301) 295-4611

News Archive

Expert warns that UK employers may face legal action over COVID-19 exposure

Employers across the UK could face legal action from employees who return to work and contract the COVID-19 virus, a leading health and safety expert has warned.

U.S. should provide more leadership in finding TB vaccine, opinion piece says

Tuberculosis deserves an effort as "substantial" as the one mounted against swine flu "to develop a new vaccine," David McMurray, a TB expert at Texas A&M University System Health Science Center, writes in a Houston Chronicle opinion piece.

Texas special legislative session on budget will deal with Medicaid; Calif. shifting Medicaid to managed care

Gov. Rick Perry was expected to begin weighing a Republican presidential bid this week but instead found himself enmeshed again in the battle over the state budget. Political watchers here will scrutinize the governor's special-session agenda for clues to his national intentions. So far, besides the budget, it includes a long-term overhaul of Medicaid and redrawing congressional districts.

Abnormal blood clotting is a major cause of death in COVID-19 patients

A study led by clinician scientists at RCSI University of Medicine and Health Sciences has found that Irish patients admitted to hospital with severe COVID-19 infection are experiencing abnormal blood clotting that contributes to death in some patients.

Calibra Medical's Finesse insulin patch-pen receives FDA clearance for use with Novo Nordisk's Novolog

Calibra Medical announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse™ insulin patch-pen for up to three-day use with Novo Nordisk's Novolog® rapid acting insulin. Combining the mealtime therapy-adherence benefits of insulin pumps with the simplicity and affordability of syringes and pens, Calibra's novel bolus-only patch-pen is a small, adhesively attached, flat device that can be operated discretely through clothing to deliver mealtime, snack time, and correction bolus insulin in seconds.

Dr Nicole Sherron Carter-loebig, MD, CNM - Medicare Student in an Organized Health Care Education/Training Program in Bethesda, MD